International Clinical Trial: A Double-Blind, Randomized Controlled, Multicenter Study on Granulocyte Colony-Stimulating Factor for the Treatment of Unexplained Recurrent Spontaneous Abortion

Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118421) titled 'A Double-Blind, Randomized Controlled, Multicenter Study on Granulocyte Colony-Stimulating Factor for the Treatment of Unexplained Recurrent Spontaneous Abortion' on Feb. 5.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Women's Hospital School of Medicine Zhejiang University

Condition: Unexplained Recurrent Spontaneous Abortion

Intervention: Experimental Group:G-CSF (Filgrastim, product of Kirin Kunpeng [China] Pharmaceuticals Co., Ltd., 75µg/0.3ml per vial) is administered at a dose of 150µg (equivalent to two vials). Administration begins on the day of a positive ovul...